product recall
Product Recall Due To a Quality Issue
The product recall I will be discussing is that of Motrin Infants drops which occurred in early September of this year. These infant drops are manufactured and distributed by Johnson & Johnson in the US through their subsidiary McNeil Consumer healthcare. Motrin is a baby drop formula used to treat fever, aches and pains in children 2 years or younger (webMD.com 2013). The recall occurred when plastic particles the size of a poppy seed were found in a batch which had not yet been released into the market. On investigation Johnson & Johnson identified that the ibuprofen used in the drops which is sourced from an outside vendor was the source for the plastic particulates. Johnson & Johnson then identified that 3 batches which had been released into the market had contained the affected batch of ibuprofen received from the vendor and recalled all bottles manufactured with this ibuprofen. This was estimated to be total of 200,000 bottles of Motrin baby drops (Beasley, 2013).
This recall was a voluntary recall as a precaution as there were no known effects of the plastics being in the drops. However this recall has done even more damage to the Johnson & Johnson reputation as there had been recalls previous to this with other ibuprofen related products. Although this issue was traced back to an external vendor it does bring into question how well Johnson & Johnsons quality systems are being adhered to. .
As part of Johnson & Johnson’s ‘dedication to quality’ policy statement which is drafted in line with ISO9001:2008, it refers to its ‘global quality’ policy in which it includes the following line as one of its aims:
The product recall I will be discussing is that of Motrin Infants drops which occurred in early September of this year. These infant drops are manufactured and distributed by Johnson & Johnson in the US through their subsidiary McNeil Consumer healthcare. Motrin is a baby drop formula used to treat fever, aches and pains in children 2 years or younger (webMD.com 2013). The recall occurred when plastic particles the size of a poppy seed were found in a batch which had not yet been released into the market. On investigation Johnson & Johnson identified that the ibuprofen used in the drops which is sourced from an outside vendor was the source for the plastic particulates. Johnson & Johnson then identified that 3 batches which had been released into the market had contained the affected batch of ibuprofen received from the vendor and recalled all bottles manufactured with this ibuprofen. This was estimated to be total of 200,000 bottles of Motrin baby drops (Beasley, 2013).
This recall was a voluntary recall as a precaution as there were no known effects of the plastics being in the drops. However this recall has done even more damage to the Johnson & Johnson reputation as there had been recalls previous to this with other ibuprofen related products. Although this issue was traced back to an external vendor it does bring into question how well Johnson & Johnsons quality systems are being adhered to. .
As part of Johnson & Johnson’s ‘dedication to quality’ policy statement which is drafted in line with ISO9001:2008, it refers to its ‘global quality’ policy in which it includes the following line as one of its aims:
Bibliography: Beasley, D. 2013. J&J unit issues U.S. recall of Motrin drops for infants. [online] Available at: http://www.reuters.com/article/2013/09/06/us-jj-recall-idUSBRE98512M20130906 [Accessed: 25 Sep 2013]. Thomas, K. 2013. Log In - The New York Times. [online] Available at: http://www.nytimes.com/2013/09/13/business/new-recalls-by-johnson-johnson-raise-concern-about-quality-control-improvements.html?_r=0 [Accessed: 3 Oct 2013]. www.jnj.com. 2013. Ingredient safety. [online] Available at: http://www.jnj.com/sites/default/files/pdf/ingredient-safety.pdf [Accessed: 30 Sep 2013]. Webmd.com. 2013. Motrin Infants Formula Recalled – WebMD. [online] Available at: http://www.webmd.com/parenting/baby/news/20130909/motrin-infants-formula-recall [Accessed: 20 Sep 2013].